Push To Create Ultra-Rare Orphan Drug Designation Finds Resistance At US FDA

 
• By Derrick Gingery
  
roadblock
Without FDA support, passing legislation to create ultra-orphan incentives will become more difficult. • Source: Shutterstock

More from Rare Diseases

More from Pink Sheet